Clinical Trial Update: Bladder EpiCheck Product Development Study

View source ↗

Summary

This clinical trial update indicates that Nucleix Ltd.'s Bladder EpiCheck product development study is currently recruiting to evaluate its use in suspected bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bladder EpiCheck

Snippet

Sponsor: Nucleix Ltd. | Conditions: Suspicion of Bladder Cancer, NMIBC Surveillance | Status: RECRUITING